UpdateBot at 19:05, 3 April 2022

2022-04-03T19:05:00Z

New page

{{Short description|Indian biopharmaceutical company}}
{{EngvarB|date=April 2014}}
{{Use dmy dates|date=April 2014}}
{{Infobox company
| name = Biological E Limited
| logo = Biological E logo.jpg
| logo_caption =
| image =
| image_size =
| image_caption =
| type = [[Private company|Private]]
| founder = Datla Venkata Krishnam Raju
| key_people = Mahima Datla (Managing Director)<ref>{{cite news |title=Hyderabad's Biological E: The Dark Horse In India's Vaccine Race |url=https://www.forbesindia.com/article/innovation/hyderabads-biological-e-the-dark-horse-in-indias-vaccine-race/64733/1 |access-date=24 May 2021 |work=Forbes India |language=en}}</ref>
| foundation = {{start date and age|1953}}
| location = [[Jubilee Hills, Hyderabad, Telangana]], India
| num_employees = 2500
| industry = [[Biotechnology]], [[Biopharmaceutical]]s
| products =
| revenue =
| Value =
| net_income =
| homepage = {{url|www.biologicale.com}}
}}

'''Biological E Limited''' (also known as '''BioE''') is an Indian [[biotechnology]] and [[biopharmaceutical]] company based in [[Hyderabad, Telangana]]. It specialises in the areas of low-cost vaccine production.<ref>{{cite web|url=http://www.thehindubusinessline.com/companies/biological-e-cuts-childrens-vaccine-price-by-30/article4634028.ece |title=Biological E cuts children's vaccine price by 30% |publisher=thehindubusinessline.com/ |date= |access-date=19 April 2013}}</ref>

==History==
The company was founded by Dr. D.V.K. Raju and Mr. G.A.N. Raju in 1953 as Biological Products Private Limited. It was among the first private sector companies in India to manufacture biological products.<ref>{{cite web|url=http://www.icra.in/Files/Reports/Rationale/Biological_E_%20-R-11262010.pdf |title=Biological E Limited |publisher=icra.in |date= |access-date=13 March 2012}}</ref> It pioneered Heparin production in India.<ref name="about">{{cite web |title=Setting up manufacturing facilities for Pneumococcal Conjugate Vaccine. |url=http://tdb.gov.in/wp-content/uploads/2017/01/Write-up_BiologicalE.pdf |website=www.tdb.gov.in |publisher=[[Technology Development Board]] |access-date=25 April 2021}} {{PD-notice}}</ref>

In 1964, Evans Medicals, a U.K. based Pharma Company, which later got merged with Glaxo SmithKline acquired 40% stake in the company, which was subsequently bought back by the promoters in 1995.{{Citation needed|date=April 2021}}

During the 1960s and 70s, Biological E developed formulations in cough and digestive enzymes, started manufacturing anti-tetanus serum, and launched anti-TB drugs, TT and DTP vaccines.<ref name="about"/>

Biological E embarked specialise in low-cost vaccines manufacturing. The company started manufacturing its flagship vaccine product, Pentavalent (DTP Hib HepB) in 2008.<ref name="about"/> Biological E is a major supplier of vaccines to international development and aid organisations such as [[WHO]], [[UNICEF]], [[BMGF]].<ref name="about"/>

==COVID-19 vaccine development==
{{main article|Corbevax}}

During the [[COVID-19 pandemic]], the company signed a pact with [[Baylor College of Medicine]], [[Texas Children's Hospital]] and Dynavax Technologies to develop a [[COVID-19 vaccine]].<ref>{{Cite web|url=https://www.livemint.com/news/india/biological-e-starts-human-trials-of-baylor-college-s-covid-19-vaccine-11605525030199.html|title=Biological E initiates human trials of vaccine|first=Leroy|last=Leo|date=16 November 2020|website=mint}}</ref><ref>{{cite news |title=Coronavirus {{!}} Biological E. inks pacts with Johnson & Johnson, Baylor College of Medicine on vaccine |url=https://www.thehindu.com/business/Industry/coronavirus-biological-e-inks-pacts-with-johnson-johnson-baylor-college-of-medicine-on-vaccine/article32345582.ece |access-date=21 March 2021 |work=The Hindu |date=13 August 2020 |language=en-IN}}</ref> The vaccine Corbevax<ref>{{Cite web|last=Bharadwaj|first=Swati|date=3 June 2021|title=Bio E to get Rs 1,500 crore advance from government to reserve 30 crore doses of Corbevax|url=https://timesofindia.indiatimes.com/business/india-business/bio-e-to-get-rs-1500-crore-advance-from-government-to-reserve-30-crore-doses-of-corbevax/articleshow/83197897.cms|url-status=live|access-date=2021-06-03|website=The Times of India|language=en|archive-url=https://web.archive.org/web/20210603065628/http://timesofindia.indiatimes.com/business/india-business/bio-e-to-get-rs-1500-crore-advance-from-government-to-reserve-30-crore-doses-of-corbevax/articleshow/83197897.cms |archive-date=3 June 2021 }}</ref>/[[Bio E COVID-19]] is expected to rollout in 2021 with 75 to 80 million doses manufactured per month; the production is expected to reach 1 billion doses by the end of 2022 under the [[Quadrilateral Security Dialogue|Quad initiative]].<ref>{{cite news |title=Meet Bio E: India’s Oldest Private Vaccine Maker Making 1 Billion Covid Doses |url=https://www.indiatimes.com/technology/news/bio-e-india-vaccine-maker-making-1-billion-covid-doses-539279.html |access-date=24 May 2021 |work=IndiaTimes |date=2021-05-02 |language=en-IN}}</ref><ref>{{cite news |title=Biological E covid vaccine: Biological E set for Covid vaccine rollout by August|url=https://timesofindia.indiatimes.com/business/india-business/biological-e-set-for-covid-vaccine-rollout-by-august/articleshow/82445644.cms |access-date=24 May 2021 |work=The Times of India |language=en}}</ref>

In August 2020, the company signed a deal with [[Johnson & Johnson]] to manufacture the latter's vaccine candidate at its Hyderabad facility.<ref>{{cite news |title=Biological E to manufacture Janssen's Covid-19 vaccine |url=https://www.pharmaceutical-technology.com/news/biological-e-covid-vaccine-deals/ |access-date=24 May 2021 |work=www.pharmaceutical-technology.com}}</ref> In February 2021, it announced that it will produce over 600 million doses of the single-dose [[Janssen COVID-19 vaccine|Janssen vaccine]] annually.<ref>{{cite news |title=Biological E looking to make 600 million Johnson and Johnson vaccine shots a year |url=https://timesofindia.indiatimes.com/india/biological-e-looking-to-make-600-million-johnson-and-johnson-vaccine-shots-a-year/articleshow/80783227.cms |access-date=21 March 2021 |work=The Times of India |language=en}}</ref><ref>{{cite news |last1=Leo |first1=Leroy |title=Biological E: The mass producer of Johnson & Johnson vaccine |url=https://www.livemint.com/companies/news/biological-e-the-mass-producer-of-johnson-johnson-vaccine-11616235431098.html |access-date=21 March 2021 |work=mint |date=20 March 2021 |language=en}}</ref>

==References==
{{Reflist}}

{{Authority control}}

[[Category:Biotechnology companies of India]]
[[Category:Manufacturing companies based in Hyderabad, India]]
[[Category:Pharmaceutical companies established in 1953]]
[[Category:Indian companies established in 1953]]
[[Category:Biopharmaceutical companies]]
[[Category:COVID-19 vaccine producers]]

Biological E. Limited - Revision history

UpdateBot at 19:05, 3 April 2022